A PYMNTS Company

U.S.: Pharmaceutical feud continues on in antitrust case

By  |  November 1, 2012

A longtime antirust suit against King Pharmaceuticals Inc. and Mutual Pharmaceutical Co. Inc. has been re-ignited by SigmaPharm Inc. The plaintiff is accusing the two companies of a conspiracy to suppress the release of Skelaxin, a brand name owned by King, therefore robbing SigmaPharm of its share in royalties over the generic brand. The suit was filed in Pennsylvania federal court.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: Law360

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.